Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

538944 U-46619 - CAS 56985-40-1 - Calbiochem

538944
  
Purchase on Sigma-Aldrich

Přehled

Replacement Information

Tabulka spec. kláve

CAS #Empirical Formula
56985-40-1C₂₁H₃₄O₄
Description
OverviewStable thromboxane A2 mimetic and a vasoconstrictor.
Catalogue Number538944
Brand Family Calbiochem®
Synonyms9,11-Dideoxy-9α,11α-methanoepoxyprostaglandin F
References
ReferencesSametz, W., et al. 1999. Eur. J. Pharmacol. 378, 47.
Kaye, D., et al. 1997. Eur. J. Pharmacol. 340, 187.
Product Information
CAS number56985-40-1
ATP CompetitiveN
FormClear colorless liquid
FormulationIn methyl acetate.
Hill FormulaC₂₁H₃₄O₄
Chemical formulaC₂₁H₃₄O₄
ReversibleN
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
ApplicationU-46619, CAS 56985-40-1, is a stable thromboxane A2 mimetic and a vasoconstrictor. Acts as a thromboxane receptor agonist (EC50 = 35 nM).
Biological Information
Primary TargetStable thromboxane A2 mimetic and a vasoconstrictor.
Purity≥98% by TLC; ≥98% by HPLC
Concentration Label Please refer to vial label for lot-specific concentration
Physicochemical Information
Cell permeableN
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
RTECSMJ9681090
Safety Information
R PhraseR: 11-20/21/22-36/37/38

Highly flammable.
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
S PhraseS: 3/7/9-16-26-36

Keep container tightly closed, in a cool well ventilated place.
Keep away from sources of ignition - No Smoking.
In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
Wear suitable protective clothing.
Product Usage Statements
Storage and Shipping Information
Ship Code Blue Ice Only
Toxicity Flammable
Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
Storage -20°C
Do not freeze Ok to freeze
Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C). Just prior to use, evaporate to dryness under a stream of nitrogen and dissolve in DMSO or EtOH (100 mg/ml).
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalogové číslo GTIN
538944 0

Documentation

U-46619 - CAS 56985-40-1 - Calbiochem MSDS

Title

Safety Data Sheet (SDS) 

U-46619 - CAS 56985-40-1 - Calbiochem Certificates of Analysis

TitleLot Number
538944

References

Přehled odkazů
Sametz, W., et al. 1999. Eur. J. Pharmacol. 378, 47.
Kaye, D., et al. 1997. Eur. J. Pharmacol. 340, 187.

Brochure

Title
Bioactive Lipids Technical Bulletin

Citations

Název
  • Pal, S., et al. 2006. Journal of Cell Biology 174, 1047.
  • Data Sheet

    Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

    Revision02-September-2008 RFH
    Synonyms9,11-Dideoxy-9α,11α-methanoepoxyprostaglandin F
    DescriptionStable thromboxane A2 mimetic.
    FormClear colorless liquid
    FormulationIn methyl acetate.
    Concentration Label Please refer to vial label for lot-specific concentration
    CAS number56985-40-1
    RTECSMJ9681090
    Chemical formulaC₂₁H₃₄O₄
    Structure formulaStructure formula
    Purity≥98% by TLC; ≥98% by HPLC
    SolubilityDMSO or ethanol
    Storage -20°C
    Do Not Freeze Ok to freeze
    Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C). Just prior to use, evaporate to dryness under a stream of nitrogen and dissolve in DMSO or EtOH (100 mg/ml).
    Toxicity Flammable
    ReferencesSametz, W., et al. 1999. Eur. J. Pharmacol. 378, 47.
    Kaye, D., et al. 1997. Eur. J. Pharmacol. 340, 187.
    Citation
  • Pal, S., et al. 2006. Journal of Cell Biology 174, 1047.